Literature DB >> 29223574

Evaluation of the effects of antiepileptic drugs on folic acid uptake by human placental choriocarcinoma cells.

Yuko Kurosawa1, Ayako Furugen1, Ayako Nishimura2, Katsuya Narumi1, Masaki Kobayashi2, Ken Iseki3.   

Abstract

Folate status during pregnancy is important for fetal development and health. The placenta plays an important role in supplying the fetus with folate. Most women with epilepsy continue their medication during pregnancy. In the present study, we aimed to evaluate the effects of 16 antiepileptic drugs, clinically used for treatment of epilepsy, on folic acid uptake in two in vitro placental models, BeWo and JEG-3 cells. Short-term exposure to antiepileptic drugs had no effects on [3H]-folic acid uptake by BeWo cells. However, long-term exposure (24h) to valproic acid (VPA) increased [3H]-folic acid uptake by BeWo and JEG-3 cells. VPA treatment for 24h increased folate receptor-α (FRα) and proton-coupled folate transporter (PCFT) mRNA expression; however, it did not affect reduced folate carrier expression. These results suggested that the increase in folic acid uptake after exposure to VPA can be attributed to the induction of FRα and PCFT expression. Furthermore, the present study showed that exposure to clinical concentrations of oxcarbazepine and stiripentol reduced the viability of BeWo cells. Therefore, the findings of the present study may contribute to better understanding of the mechanisms of toxicity of antiepileptic drugs, and estimation of their potential risk to fetus.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiepileptic drug; Folate receptor-α; Folic acid; Placenta; Proton-coupled folate transporter; Reduced folate carrier

Mesh:

Substances:

Year:  2017        PMID: 29223574     DOI: 10.1016/j.tiv.2017.12.003

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  2 in total

1.  A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.

Authors:  Weiyong Hong; Fangyuan Guo; Nan Yu; Sanjun Ying; Bang Lou; Jiangqing Wu; Ying Gao; Xugang Ji; Haiying Wang; Aiqin Li; Guoping Wang; Gensheng Yang
Journal:  Drug Des Devel Ther       Date:  2021-06-30       Impact factor: 4.162

2.  Genetic Polymorphisms in Enzymes Involved in One-Carbon Metabolism and Anti-epileptic Drug Monotherapy on Homocysteine Metabolism in Patients With Epilepsy.

Authors:  Shaofang Zhu; Guanzhong Ni; Lisen Sui; Yiran Zhao; Xiaoxu Zhang; Qilin Dai; Aohan Chen; Wanrong Lin; Yinchao Li; Min Huang; Liemin Zhou
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.